HDAC (Histone Deacetylase) Inhibitor Valproic Acid Attenuates Atrial Remodeling and Delays the Onset of Atrial Fibrillation in Mice-Reference-Cited by-同舟云学术

HDAC (Histone Deacetylase) Inhibitor Valproic Acid Attenuates Atrial Remodeling and Delays the Onset of Atrial Fibrillation in Mice

Published:2019-03 Issue:3 Volume:12 Page:
ISSN:1941-3149
Container-title:Circulation: Arrhythmia and Electrophysiology
language:en
Short-container-title:Circ: Arrhythmia and Electrophysiology

Author:

Scholz Beatrix¹,Schulte Jan Sebastian¹,Hamer Sabine¹,Himmler Kirsten¹,Pluteanu Florentina¹,Seidl Matthias Dodo¹,Stein Juliane¹,Wardelmann Eva²,Hammer Elke³⁴,Völker Uwe³⁴,Müller Frank Ulrich¹

Affiliation:

1. Institute of Pharmacology and Toxicology, University of Münster, Germany (B.S., J.S.S., S.H., K.H., F.P., M.D.S., J.S., F.U.M.).

2. Gerhard-Domagk-Institute of Pathology, University Hospital Münster, Germany (E.W.).

3. Interfaculty Institute of Genetics und Functional Genomics, University Medicine Greifswald, Germany (E.H., U.V.).

4. DZHK (German Centre for Cardiovascular Research), partner site Greifswald, Germany (E.H., U.V.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference71 articles.

1. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

2. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060

3. Pathophysiological Mechanisms of Atrial Fibrillation: A Translational Appraisal

4. Novel molecular targets for atrial fibrillation therapy

5. Left Atrial Transcriptional Changes Associated With Atrial Fibrillation Susceptibility and Persistence

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic regulation of diverse regulated cell death modalities in cardiovascular disease: Insights into necroptosis, pyroptosis, ferroptosis, and cuproptosis;Redox Biology;2024-10

2. Role of histone deacetylase inhibitors in non-neoplastic diseases;Heliyon;2024-07

3. Targeting histone deacetylase in cardiac diseases;Frontiers in Physiology;2024-06-24

4. Interleukin-33/ST2 axis involvement in atrial remodeling and arrhythmogenesis;Translational Research;2024-06

5. Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa;British Journal of Dermatology;2024-05-31